Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPT-ACS
NCT07684742Phase 4Not yet recruiting
- Sponsor
- Gyeongsang National University Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, prasugrel in acute coronary syndrome (ACS), sponsored by Gyeongsang National University Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ticagrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07684742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684742.